- Home
- / Roka Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Roka Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$109.5 M
Revenue
$7.2 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
| Revenue | 5.1M | 6.0M | 7.2M |
| Revenue growth, % | 18.4% | 21.0% | |
| Cost of goods sold | 7.8M | 7.7M | 8.0M |
| Gross profit | (2.8M) | (1.7M) | (732.0K) |
| Gross profit margin, % | -55.2% | -28.7% | -10.1% |
| General and administrative expense | 19.1M | 21.8M | 17.7M |
| Operating expense total | 28.8M | 33.6M | 28.8M |
| Depreciation and amortization | 1.8M | 3.7M | 3.8M |
| EBIT | (31.6M) | (35.3M) | (29.5M) |
| EBIT margin, % | -624.7% | -589.7% | -407.1% |
| Interest expense | 1.8M | 2.0M | 1.6M |
| Pre tax profit | (34.2M) | (37.3M) | (31.0M) |
| Income tax expense | (2.0M) | (700.0K) | (245.0K) |
| Net Income | (32.2M) | (36.6M) | (30.8M) |